Published in Ann Surg Oncol on September 01, 2013
Oligometastatic breast cancer: a shift from palliative to potentially curative treatment? Breast Care (Basel) (2014) 0.91
Resection of the primary tumor in stage IV breast cancer. World J Clin Oncol (2014) 0.78
Supporting trials for primary tumor resection in stage IV breast cancer is paramount. Ann Surg Oncol (2013) 0.75
The survival benefits of local surgery in stage IV breast cancer are not affected by breast cancer subtypes: a population-based analysis. Oncotarget (2017) 0.75
A meta-analysis of human acellular dermis and submuscular tissue expander breast reconstruction. Plast Reconstr Surg (2012) 3.30
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw (2009) 2.78
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol (2014) 2.38
Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg (2012) 2.20
What are safe margins of resection for invasive and in situ breast cancer? Oncology (Williston Park) (2011) 2.08
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res (2006) 1.58
Effect of MRI on the management of ductal carcinoma in situ of the breast. Ann Surg Oncol (2012) 1.46
alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat (2007) 1.29
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol (2014) 1.28
Primary tumor resection in stage IV breast cancer: consistent benefit, or consistent bias? Ann Surg Oncol (2007) 1.13
Morphological changes in breast tissue with menstrual cycle. Mod Pathol (2002) 1.08
A comparison of ductoscopy-guided and conventional surgical excision in women with spontaneous nipple discharge. Ann Surg (2005) 1.08
Array-based multiplex analysis of DNA methylation in breast cancer tissues. J Mol Diagn (2007) 1.07
Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer. Cancer (2008) 1.06
Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge. Clin Cancer Res (2009) 1.05
Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.01
Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.01
Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res (2005) 1.00
Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations. Cancer Epidemiol Biomarkers Prev (2010) 0.97
Association between recency of last pregnancy and biologic subtype of breast cancer. Ann Surg Oncol (2011) 0.96
Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women. Breast Cancer Res Treat (2007) 0.95
Effect of size, surface charge, and hydrophobicity of poly(amidoamine) dendrimers on their skin penetration. Biomacromolecules (2012) 0.94
Contralateral prophylactic mastectomy: what do we know and what do our patients know? J Clin Oncol (2011) 0.93
Formation of estrone and estradiol from estrone sulfate by normal breast parenchymal tissue. J Steroid Biochem Mol Biol (2003) 0.91
A prospective study of variability in mammographic density during the menstrual cycle. Breast Cancer Res Treat (2009) 0.90
Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinoma. J Am Coll Surg (2005) 0.88
Breast ductal lavage for assessment of breast cancer biomarkers. Horm Cancer (2010) 0.87
Normal breast lobular architecture in breast biopsy samples from breast cancer cases and benign disease controls. Breast Cancer Res Treat (2004) 0.87
Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentary. Cancer (2002) 0.86
Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept. J Clin Oncol (2009) 0.86
COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ. BMC Cancer (2008) 0.85
Tissue-specific transcripts of human steroid sulfatase are under control of estrogen signaling pathways in breast carcinoma. J Steroid Biochem Mol Biol (2007) 0.85
Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications. Arch Pathol Lab Med (2010) 0.85
Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer (2006) 0.84
Tumescent technique does not increase the risk of complication following mastectomy with immediate reconstruction. Ann Surg Oncol (2013) 0.84
The differential effect of BMI on prosthetic versus autogenous breast reconstruction: a multivariate analysis of 12,986 patients. Breast (2013) 0.83
Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib. Breast Cancer Res Treat (2011) 0.83
Factors associated with the development of chronic pain after surgery for breast cancer: a prospective cohort from a tertiary center in the United States. Breast J (2013) 0.83
RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. Breast Cancer Res Treat (2014) 0.82
The many questions that surround multicentric and multifocal breast cancer. Breast J (2010) 0.81
Comment on "Progesterone/RANKL is a major regulatory axis in the human breast". Sci Transl Med (2013) 0.81
Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls. Cancer Epidemiol Biomarkers Prev (2013) 0.80
Reversed acellular dermis: failure of graft incorporation in primary tissue expander breast reconstruction resulting in recurrent breast cellulitis. Plast Reconstr Surg (2010) 0.80
Local therapy for the primary breast tumor in women with metastatic disease. Clin Adv Hematol Oncol (2011) 0.80
Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579). Breast Cancer Res Treat (2015) 0.79
Isolation of highly purified DNA from low-abundance archived and stained cytological specimens. Clin Chim Acta (2006) 0.78
Lipid metabolism genes in contralateral unaffected breast and estrogen receptor status of breast cancer. Cancer Prev Res (Phila) (2013) 0.78
Individualized risk of surgical-site infection: an application of the breast reconstruction risk assessment score. Plast Reconstr Surg (2014) 0.78
Abstract 46: The BRA Score: Creating a General Risk Calculator for Breast Reconstruction Outcomes. Plast Reconstr Surg (2014) 0.77
Expression of estrogen-related gene markers in breast cancer tissue predicts aromatase inhibitor responsiveness. PLoS One (2013) 0.77
Prediction of menopausal status from estrogen-related gene expression in benign breast tissue. Breast Cancer Res Treat (2011) 0.77
Pathologic findings in contralateral reduction mammaplasty specimens in patients with breast cancer. Breast J (2005) 0.77
Novel agents for chemoprevention, screening methods, and sampling issues. J Mammary Gland Biol Neoplasia (2003) 0.76
Local therapy for breast cancer in the molecular era: relevant or relic? Oncology (Williston Park) (2014) 0.75
Hepatic metastasectomy for breast cancer and melanoma: trends in highly selected patients. Oncology (Williston Park) (2011) 0.75
Reply: To PMID 23211118. J Am Coll Surg (2013) 0.75
A fitting prescription for all:whole soyfoods as part of a varied plant-based diet. Oncology (Williston Park) (2013) 0.75
Evidence-Based Clinical Practice Guideline: Autologous Breast Reconstruction with DIEP or Pedicled TRAM Abdominal Flaps. Plast Reconstr Surg (2017) 0.75
Post-mastectomy reconstruction: a risk-stratified comparative analysis of outcomes. Breast (2013) 0.75
A Randomized, Double-Blinded, Placebo-Controlled Trial of Simvastatin to Prevent Recurrent Pancreatitis. Pancreas (2022) 0.75
Expression of interleukin-6 and tumor necrosis factor alpha and histopathologic findings in painful and nonpainful breast tissue. Breast J (2003) 0.75
Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev (2005) 0.75